163 related articles for article (PubMed ID: 33679918)
1. Association of serum chemerin with calcium, alkaline phosphatase and bone mineral density in postmenopausal females.
Tariq S; Tariq S; Shahzad M
Pak J Med Sci; 2021; 37(2):384-388. PubMed ID: 33679918
[TBL] [Abstract][Full Text] [Related]
2. Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females.
Tariq S; Tariq S; Lone KP; Khaliq S
Pak J Med Sci; 2019; 35(3):749-753. PubMed ID: 31258588
[TBL] [Abstract][Full Text] [Related]
3. Serum tumour necrosis factor alpha in osteopenic and osteoporotic postmenopausal females: A cross-sectional study in Pakistan.
Murad R; Shezad Z; Ahmed S; Ashraf M; Qadir M; Rehman R
J Pak Med Assoc; 2018 Mar; 68(3):428-431. PubMed ID: 29540879
[TBL] [Abstract][Full Text] [Related]
4. Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health.
Tariq S; Tariq S; Khaliq S; Baig M; Murad MA; Lone KP
Front Endocrinol (Lausanne); 2020; 11():615440. PubMed ID: 33519717
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females.
Tariq S; Tariq S; Abualhamael SA; Shahzad M
Front Pharmacol; 2022; 13():822671. PubMed ID: 35222038
[TBL] [Abstract][Full Text] [Related]
6. Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females.
Tariq S; Tariq S; Khaliq S; Abualhamael SA; Baig M
Front Endocrinol (Lausanne); 2022; 13():1024860. PubMed ID: 36531488
[TBL] [Abstract][Full Text] [Related]
7. Association of High Serum Chemerin with Bone Mineral Density Loss and Osteoporotic Fracture in Elderly Chinese Women.
Jiang XY; Wang Q; Zhang Y; Chen Y; Wu LF
Int J Womens Health; 2022; 14():107-118. PubMed ID: 35140527
[TBL] [Abstract][Full Text] [Related]
8. [Is there a role for a random measurement of 24-hour urine calcium excretion and serum total alkaline phosphatase in the determination of fracture risk in osteoporotic postmenopausal women?].
Barbu C; Roman A; Rotaru R; Fica S
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):291-4. PubMed ID: 17802933
[TBL] [Abstract][Full Text] [Related]
9. Relationship of anthropometric measures with bone mineral density in postmenopausal non-osteoporotic, osteopenic and osteoporotic women.
Tariq S; Tariq S; Lone KP
J Pak Med Assoc; 2017 Apr; 67(4):590-594. PubMed ID: 28420922
[TBL] [Abstract][Full Text] [Related]
10. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.
Lateef M; Baig M; Azhar A
Osteoporos Int; 2010 May; 21(5):751-5. PubMed ID: 19597912
[TBL] [Abstract][Full Text] [Related]
11. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
[TBL] [Abstract][Full Text] [Related]
12. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
Pirro M; Mannarino MR; Bianconi V; De Vuono S; Sahebkar A; Bagaglia F; Franceschini L; Scarponi AM; Mannarino E; Merriman T
Osteoporos Int; 2017 Mar; 28(3):973-981. PubMed ID: 27725998
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
14. Bone Turnover Markers for Osteoporosis Status Assessment at Baseline in Postmenopausal Pakistani Females.
Naeem ST; Hussain R; Raheem A; Siddiqui I; Ghani F; Khan AH
J Coll Physicians Surg Pak; 2016 May; 26(5):408-12. PubMed ID: 27225148
[TBL] [Abstract][Full Text] [Related]
15. Bone Alkaline Phosphatase and Urine Hydroxyproline Assay in Pre and Postmenopausal Women in the State of Sikkim and its Correlation with Bone Mineral Density.
Rai AD; Sherpa ML; Singh A; Thejaswi SG; Bhutia RD
J Midlife Health; 2021; 12(4):304-309. PubMed ID: 35264838
[TBL] [Abstract][Full Text] [Related]
16. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
Watts NB; Jenkins DK; Visor JM; Casal DC; Geusens P
Osteoporos Int; 2001; 12(4):279-88. PubMed ID: 11420777
[TBL] [Abstract][Full Text] [Related]
18. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study.
Ross PD; Kress BC; Parson RE; Wasnich RD; Armour KA; Mizrahi IA
Osteoporos Int; 2000; 11(1):76-82. PubMed ID: 10663362
[TBL] [Abstract][Full Text] [Related]
19. Effect of ibandronate therapy on serum homocysteine and leptin in postmenopausal osteoporotic females.
Tariq S; Tariq S; Alam SS; Baig M
Osteoporos Int; 2015 Mar; 26(3):1187-92. PubMed ID: 25274281
[TBL] [Abstract][Full Text] [Related]
20. The association of serum osteocalcin with the bone mineral density in post menopausal women.
Vs K; K P; Ramesh M; Venkatesan V
J Clin Diagn Res; 2013 May; 7(5):814-6. PubMed ID: 23814717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
